Glioma, non-small cell lung cancer, head and neck, breast, colorectal, ovarian, prostatic and pancreatic cancers are known to all exhibit increased EGFR activity [23], which is considerably beneficial to survival and growth of these cancer cells [24,25]. Here, EGFR is linked to central nervous system cancer.